NCT02979821 2018-05-24Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001)Korean Association for the Study of Targeted TherapyPhase 2 Completed6 enrolled
NCT01819428 2016-03-01NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung AdenocarcinomaNational OncoVenturePhase 2 Terminated22 enrolled